Ruggie Capital Group’s iRadimed IRMD Stock Holding History

Ruggie Capital Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,400	Closed	-$34K	–	295
2018 Q4	$34K	Buy	+1,400	New	+$37.6K	0.02%	197

Other funds holding IRMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ruggie Capital Group's IRMD Position: Q1 2019 in Review

Ruggie Capital Group sold out of iRadimed (IRMD) in Q1 2019, closing a stake of 1,400 shares — an estimated $34K sold.

Ruggie Capital Group first reported a position in IRMD in Q4 2018 and held it in 1 quarter. The position peaked at $34K in Q4 2018. 64 funds tracked by Wall St. Rank hold IRMD as of Q1 2019.

Ruggie Capital Group reported no remaining iRadimed position as of Q1 2019 after selling out during the quarter.
Ruggie Capital Group sold 1,400 iRadimed shares in Q1 2019, an estimated $34K.
Ruggie Capital Group first reported a position in iRadimed in Q4 2018 and held it in 1 quarter.
Ruggie Capital Group's iRadimed position peaked at $34K in Q4 2018.
64 funds tracked by Wall St. Rank held iRadimed as of Q1 2019.

Based on Ruggie Capital Group's 13F filing for Q1 2019, filed 24 Apr 2019.